gl261 luc cells Search Results


90
iCell Bioscience Inc mouse gbm cell lines gl261
Mouse Gbm Cell Lines Gl261, supplied by iCell Bioscience Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gl261+luc+cells/gl261+++luc+cell+specific+medium/pm38342629-295-1-11
Average 90 stars, based on 1 article reviews
mouse gbm cell lines gl261 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
iCell Gene Therapeutics gl261 cell line
Evaluations of PQ 2 + or PQ + clearance in the brains of mice and in cultured astrocytes with or without DRP1 knockdown. (A,B) In vivo extracellular residue of the loading PQ 2 + ( PQ 2 + -LT ) was detected by microdialysis followed by HPLC in WT (A) and O c t 3 − / − (B) mice treated with either empty AAV control, neuronal DRP knockdown by AAV, astrocyte DRP1 knockdown by AAV, or non-selective DRP1 knockdown using mdivi-1. n = 5 mice per group. One-way ANOVA was followed by the Bonferroni multiple comparison test. Data are shown as mean ± SD . (C,D) PQ 2 + or PQ + uptake assays of <t>GL261</t> astrocytes without or with SDT. PQ 2 + / PQ + concentration in the extracellular culture medium ranged from 0 to 800 μ M ( x -axis), and the uptake level of PQ 2 + / PQ + into astrocytes were detected in the cell lysate ( y -axis). Drp-1 siRNA was used to knockdown DRP1 in GL261 astrocytes. The average area under the curves were calculated and used for statistical analysis. n = 6 independent experiments per group. One-way ANOVA was followed by the Bonferroni multiple comparison test. Data are shown as mean ± SEM . **, p < 0.01 ; ***, p < 0.001 . The numeric data are shown in Excel Table S5. Note: AAV, adeno-associated virus; ANOVA, analysis of variance; Astro-DRP1 KD, DRP1 knockdown in astrocytes by AAV with gfaABC1D promoter; DRP1, dynamic related protein-1; HPLC, high-performance liquid chromatography; LT, loading treatment; mdivi-1, mitochondrial division inhibitor-1; Neuro-DRP1 KD, DRP1 knockdown in neuron by AAV with hsyn promoter; oct3, organic cation transporter-3; PQ, paraquat; Scramble, empty AAV for control; SD, standard deviation; SDT, sodium dithionite; SEM, standard error of the mean; siRNA, small interfering RNA; WT, wild-type.
Gl261 Cell Line, supplied by iCell Gene Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gl261+luc+cells/luciferase+transfected+glioblastoma+cell+lines+gl261+luc/pmc09070608-70-5-24
Average 90 stars, based on 1 article reviews
gl261 cell line - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Creative Biolabs gl261-luc murine glioblastoma cell line
Barrier permeation enhancement effect of EVs and efficient delivery of aPD-L1/EV into brain. ( A ) Scheme of the in vitro barrier permeation test with C2BBe1 trans-well system (created from Biorender.com ). ( B ) Amounts of permeated aPD-L1 with free aPD-L1 or aPD-L1/EV administration through the C2BBe1 barrier. ( C ) Comparison of drug delivery efficiency with RO or IN administration of FITC-conjugated IgG or IgG/EV. The upper column displays the fluorescence of IgG within brain sections, and the lower column shows the cumulative fluorescence intensity of brain sections. ( D ) Distribution of aPD-L1 in <t>GL261</t> tumor-bearing mice. Green fluorescence indicates aPD-L1, and nuclei were stained with DAPI. Statistics in ( B, C ) were conducted by one-way ANOVA with Bonferroni post hoc test. Asterisks represent a significant difference between indicated groups, with significance defined as p < 0.05. Data were presented as mean ± SD with n = 3.
Gl261 Luc Murine Glioblastoma Cell Line, supplied by Creative Biolabs, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gl261+luc+cells/gl261+luc+murine+glioblastoma+cell+line/pmc11421369-58-1-9
Average 90 stars, based on 1 article reviews
gl261-luc murine glioblastoma cell line - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
RWD Life Science gl261-luc (wt/ko) tumor cells
Barrier permeation enhancement effect of EVs and efficient delivery of aPD-L1/EV into brain. ( A ) Scheme of the in vitro barrier permeation test with C2BBe1 trans-well system (created from Biorender.com ). ( B ) Amounts of permeated aPD-L1 with free aPD-L1 or aPD-L1/EV administration through the C2BBe1 barrier. ( C ) Comparison of drug delivery efficiency with RO or IN administration of FITC-conjugated IgG or IgG/EV. The upper column displays the fluorescence of IgG within brain sections, and the lower column shows the cumulative fluorescence intensity of brain sections. ( D ) Distribution of aPD-L1 in <t>GL261</t> tumor-bearing mice. Green fluorescence indicates aPD-L1, and nuclei were stained with DAPI. Statistics in ( B, C ) were conducted by one-way ANOVA with Bonferroni post hoc test. Asterisks represent a significant difference between indicated groups, with significance defined as p < 0.05. Data were presented as mean ± SD with n = 3.
Gl261 Luc (Wt/Ko) Tumor Cells, supplied by RWD Life Science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gl261+luc+cells/gl261+luc++wt+ko++tumor+cells/pm39487896-58-22-39
Average 90 stars, based on 1 article reviews
gl261-luc (wt/ko) tumor cells - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Korean Cell Line Bank gl261-luc cells
Barrier permeation enhancement effect of EVs and efficient delivery of aPD-L1/EV into brain. ( A ) Scheme of the in vitro barrier permeation test with C2BBe1 trans-well system (created from Biorender.com ). ( B ) Amounts of permeated aPD-L1 with free aPD-L1 or aPD-L1/EV administration through the C2BBe1 barrier. ( C ) Comparison of drug delivery efficiency with RO or IN administration of FITC-conjugated IgG or IgG/EV. The upper column displays the fluorescence of IgG within brain sections, and the lower column shows the cumulative fluorescence intensity of brain sections. ( D ) Distribution of aPD-L1 in <t>GL261</t> tumor-bearing mice. Green fluorescence indicates aPD-L1, and nuclei were stained with DAPI. Statistics in ( B, C ) were conducted by one-way ANOVA with Bonferroni post hoc test. Asterisks represent a significant difference between indicated groups, with significance defined as p < 0.05. Data were presented as mean ± SD with n = 3.
Gl261 Luc Cells, supplied by Korean Cell Line Bank, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gl261+luc+cells/gl261+luc+cells/10__1080_slash_2162402x__2018__1525243-110-0-26
Average 90 stars, based on 1 article reviews
gl261-luc cells - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Shanghai Model Organisms Center gl261-luc cell line
Barrier permeation enhancement effect of EVs and efficient delivery of aPD-L1/EV into brain. ( A ) Scheme of the in vitro barrier permeation test with C2BBe1 trans-well system (created from Biorender.com ). ( B ) Amounts of permeated aPD-L1 with free aPD-L1 or aPD-L1/EV administration through the C2BBe1 barrier. ( C ) Comparison of drug delivery efficiency with RO or IN administration of FITC-conjugated IgG or IgG/EV. The upper column displays the fluorescence of IgG within brain sections, and the lower column shows the cumulative fluorescence intensity of brain sections. ( D ) Distribution of aPD-L1 in <t>GL261</t> tumor-bearing mice. Green fluorescence indicates aPD-L1, and nuclei were stained with DAPI. Statistics in ( B, C ) were conducted by one-way ANOVA with Bonferroni post hoc test. Asterisks represent a significant difference between indicated groups, with significance defined as p < 0.05. Data were presented as mean ± SD with n = 3.
Gl261 Luc Cell Line, supplied by Shanghai Model Organisms Center, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gl261+luc+cells/gl261+luc+cell+line/pm40334815-123-3-9
Average 90 stars, based on 1 article reviews
gl261-luc cell line - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier


Image Search Results


Evaluations of PQ 2 + or PQ + clearance in the brains of mice and in cultured astrocytes with or without DRP1 knockdown. (A,B) In vivo extracellular residue of the loading PQ 2 + ( PQ 2 + -LT ) was detected by microdialysis followed by HPLC in WT (A) and O c t 3 − / − (B) mice treated with either empty AAV control, neuronal DRP knockdown by AAV, astrocyte DRP1 knockdown by AAV, or non-selective DRP1 knockdown using mdivi-1. n = 5 mice per group. One-way ANOVA was followed by the Bonferroni multiple comparison test. Data are shown as mean ± SD . (C,D) PQ 2 + or PQ + uptake assays of GL261 astrocytes without or with SDT. PQ 2 + / PQ + concentration in the extracellular culture medium ranged from 0 to 800 μ M ( x -axis), and the uptake level of PQ 2 + / PQ + into astrocytes were detected in the cell lysate ( y -axis). Drp-1 siRNA was used to knockdown DRP1 in GL261 astrocytes. The average area under the curves were calculated and used for statistical analysis. n = 6 independent experiments per group. One-way ANOVA was followed by the Bonferroni multiple comparison test. Data are shown as mean ± SEM . **, p < 0.01 ; ***, p < 0.001 . The numeric data are shown in Excel Table S5. Note: AAV, adeno-associated virus; ANOVA, analysis of variance; Astro-DRP1 KD, DRP1 knockdown in astrocytes by AAV with gfaABC1D promoter; DRP1, dynamic related protein-1; HPLC, high-performance liquid chromatography; LT, loading treatment; mdivi-1, mitochondrial division inhibitor-1; Neuro-DRP1 KD, DRP1 knockdown in neuron by AAV with hsyn promoter; oct3, organic cation transporter-3; PQ, paraquat; Scramble, empty AAV for control; SD, standard deviation; SDT, sodium dithionite; SEM, standard error of the mean; siRNA, small interfering RNA; WT, wild-type.

Journal: Environmental Health Perspectives

Article Title: Role of OCT3 and DRP1 in the Transport of Paraquat in Astrocytes: A Mouse Study

doi: 10.1289/EHP9505

Figure Lengend Snippet: Evaluations of PQ 2 + or PQ + clearance in the brains of mice and in cultured astrocytes with or without DRP1 knockdown. (A,B) In vivo extracellular residue of the loading PQ 2 + ( PQ 2 + -LT ) was detected by microdialysis followed by HPLC in WT (A) and O c t 3 − / − (B) mice treated with either empty AAV control, neuronal DRP knockdown by AAV, astrocyte DRP1 knockdown by AAV, or non-selective DRP1 knockdown using mdivi-1. n = 5 mice per group. One-way ANOVA was followed by the Bonferroni multiple comparison test. Data are shown as mean ± SD . (C,D) PQ 2 + or PQ + uptake assays of GL261 astrocytes without or with SDT. PQ 2 + / PQ + concentration in the extracellular culture medium ranged from 0 to 800 μ M ( x -axis), and the uptake level of PQ 2 + / PQ + into astrocytes were detected in the cell lysate ( y -axis). Drp-1 siRNA was used to knockdown DRP1 in GL261 astrocytes. The average area under the curves were calculated and used for statistical analysis. n = 6 independent experiments per group. One-way ANOVA was followed by the Bonferroni multiple comparison test. Data are shown as mean ± SEM . **, p < 0.01 ; ***, p < 0.001 . The numeric data are shown in Excel Table S5. Note: AAV, adeno-associated virus; ANOVA, analysis of variance; Astro-DRP1 KD, DRP1 knockdown in astrocytes by AAV with gfaABC1D promoter; DRP1, dynamic related protein-1; HPLC, high-performance liquid chromatography; LT, loading treatment; mdivi-1, mitochondrial division inhibitor-1; Neuro-DRP1 KD, DRP1 knockdown in neuron by AAV with hsyn promoter; oct3, organic cation transporter-3; PQ, paraquat; Scramble, empty AAV for control; SD, standard deviation; SDT, sodium dithionite; SEM, standard error of the mean; siRNA, small interfering RNA; WT, wild-type.

Article Snippet: The HEK293 (Cat. No. h242), GL261 (Cat. No. m063), and Neuro-2a ( N 2 a ; Cat. No. m040) cell lines were purchased from iCell Co., Ltd.

Techniques: Cell Culture, Knockdown, In Vivo, Residue, Control, Comparison, Concentration Assay, Virus, High Performance Liquid Chromatography, Standard Deviation, Small Interfering RNA

The levels of PQ + transporters in cultured astrocytes with or without DRP1 knockdown exposed to control or PQ + . (A,B) Representative images of Western blots showing three major monovalent cation transporters in GL261 astrocytes with or without DRP1 inhibition by Drp1 siRNA or mdivi-1. Scrambled siRNA was used as control for Drp1 siRNA exposed to control or PQ + . (C–H) Quantitative analysis of the relative expression of the transporters shown in A and B. The group of PQ + (–) scramble siRNA were normalized to 1. n = 5 independent experiments. Data are shown as mean ± SEM . Two-way ANOVA followed by the Bonferroni multiple comparison test. ***, p < 0.001 . The numeric data are shown in Excel Table S6. In two-way ANOVAs, “*” was used to present the statistical difference between groups both treated by PBS or PQ 2 + . Note: 4F2hc, 4F2 heavy chain of L-type amino acid transporter 1; ANOVA, analysis of variance; ASCT2, alanine serine cysteine transporter 2; DRP1, dynamic related protein-1; mdivi-1, mitochondrial division inhibitor-1; PBS, phosphate-buffered saline; PQ, paraquat; Scramble, empty AAV for control; SEM, standard error of the mean; siRNA, small interfering RNA; SLC1A4, solute carrier family 1 member 4.

Journal: Environmental Health Perspectives

Article Title: Role of OCT3 and DRP1 in the Transport of Paraquat in Astrocytes: A Mouse Study

doi: 10.1289/EHP9505

Figure Lengend Snippet: The levels of PQ + transporters in cultured astrocytes with or without DRP1 knockdown exposed to control or PQ + . (A,B) Representative images of Western blots showing three major monovalent cation transporters in GL261 astrocytes with or without DRP1 inhibition by Drp1 siRNA or mdivi-1. Scrambled siRNA was used as control for Drp1 siRNA exposed to control or PQ + . (C–H) Quantitative analysis of the relative expression of the transporters shown in A and B. The group of PQ + (–) scramble siRNA were normalized to 1. n = 5 independent experiments. Data are shown as mean ± SEM . Two-way ANOVA followed by the Bonferroni multiple comparison test. ***, p < 0.001 . The numeric data are shown in Excel Table S6. In two-way ANOVAs, “*” was used to present the statistical difference between groups both treated by PBS or PQ 2 + . Note: 4F2hc, 4F2 heavy chain of L-type amino acid transporter 1; ANOVA, analysis of variance; ASCT2, alanine serine cysteine transporter 2; DRP1, dynamic related protein-1; mdivi-1, mitochondrial division inhibitor-1; PBS, phosphate-buffered saline; PQ, paraquat; Scramble, empty AAV for control; SEM, standard error of the mean; siRNA, small interfering RNA; SLC1A4, solute carrier family 1 member 4.

Article Snippet: The HEK293 (Cat. No. h242), GL261 (Cat. No. m063), and Neuro-2a ( N 2 a ; Cat. No. m040) cell lines were purchased from iCell Co., Ltd.

Techniques: Cell Culture, Knockdown, Control, Western Blot, Inhibition, Expressing, Comparison, Saline, Small Interfering RNA

Transport of PQ 2 + or PQ + into the GL261 astrocyte cell line with and without specific inhibitors of ASCT2 and OCT3, with and without siRNA targeting Drp-1. PQ + / PQ 2 + (with or without SDT) transportation into GL261 astrocytes was evaluated using in vitro uptake assay. Specific inhibitors (Benser for ASCT2; D22 for OCT3) were used to evaluate the role of ASCT2 and OCT3, respectively. (A,B) The intake capacity of PQ 2 + by GL261 astrocytes without (A) or with (B) Drp1 siRNA. The average area under the curve was used for statistical analysis. n = 6 independent experiments. (C,D) The intake capacity of PQ + ( PQ 2 + pretreated with SDT) by GL261 astrocytes without (C) or with (D) Drp1 siRNA. Area under the curve was analyzed. n = 6 independent experiments. PQ 2 + / PQ + concentrations in extracellular culture medium ranged from 0 to 800 μ M ( x -axis). The intake PQ 2 + / PQ + was detected in the cell lysate ( y -axis). Data are shown as the mean ± SEM . One-way ANOVA was followed by the Bonferroni multiple comparison test. *, p < 0.01 ; ***, p < 0.001 . The numeric data are shown in Excel Table S8. Note: ANOVA, analysis of variance; ASCT2, alanine serine cysteine transporter 2; Benser, benzylserine; D22, Decynium 22; DRP1, dynamic related protein-1; OCT3, organic cation transporter-3; PBS, phosphate-buffered saline; PQ, paraquat; SDT, sodium dithionite; SEM, standard error of the mean; siRNA, small interfering RNA.

Journal: Environmental Health Perspectives

Article Title: Role of OCT3 and DRP1 in the Transport of Paraquat in Astrocytes: A Mouse Study

doi: 10.1289/EHP9505

Figure Lengend Snippet: Transport of PQ 2 + or PQ + into the GL261 astrocyte cell line with and without specific inhibitors of ASCT2 and OCT3, with and without siRNA targeting Drp-1. PQ + / PQ 2 + (with or without SDT) transportation into GL261 astrocytes was evaluated using in vitro uptake assay. Specific inhibitors (Benser for ASCT2; D22 for OCT3) were used to evaluate the role of ASCT2 and OCT3, respectively. (A,B) The intake capacity of PQ 2 + by GL261 astrocytes without (A) or with (B) Drp1 siRNA. The average area under the curve was used for statistical analysis. n = 6 independent experiments. (C,D) The intake capacity of PQ + ( PQ 2 + pretreated with SDT) by GL261 astrocytes without (C) or with (D) Drp1 siRNA. Area under the curve was analyzed. n = 6 independent experiments. PQ 2 + / PQ + concentrations in extracellular culture medium ranged from 0 to 800 μ M ( x -axis). The intake PQ 2 + / PQ + was detected in the cell lysate ( y -axis). Data are shown as the mean ± SEM . One-way ANOVA was followed by the Bonferroni multiple comparison test. *, p < 0.01 ; ***, p < 0.001 . The numeric data are shown in Excel Table S8. Note: ANOVA, analysis of variance; ASCT2, alanine serine cysteine transporter 2; Benser, benzylserine; D22, Decynium 22; DRP1, dynamic related protein-1; OCT3, organic cation transporter-3; PBS, phosphate-buffered saline; PQ, paraquat; SDT, sodium dithionite; SEM, standard error of the mean; siRNA, small interfering RNA.

Article Snippet: The HEK293 (Cat. No. h242), GL261 (Cat. No. m063), and Neuro-2a ( N 2 a ; Cat. No. m040) cell lines were purchased from iCell Co., Ltd.

Techniques: In Vitro, Comparison, Saline, Small Interfering RNA

Barrier permeation enhancement effect of EVs and efficient delivery of aPD-L1/EV into brain. ( A ) Scheme of the in vitro barrier permeation test with C2BBe1 trans-well system (created from Biorender.com ). ( B ) Amounts of permeated aPD-L1 with free aPD-L1 or aPD-L1/EV administration through the C2BBe1 barrier. ( C ) Comparison of drug delivery efficiency with RO or IN administration of FITC-conjugated IgG or IgG/EV. The upper column displays the fluorescence of IgG within brain sections, and the lower column shows the cumulative fluorescence intensity of brain sections. ( D ) Distribution of aPD-L1 in GL261 tumor-bearing mice. Green fluorescence indicates aPD-L1, and nuclei were stained with DAPI. Statistics in ( B, C ) were conducted by one-way ANOVA with Bonferroni post hoc test. Asterisks represent a significant difference between indicated groups, with significance defined as p < 0.05. Data were presented as mean ± SD with n = 3.

Journal: Materials Today Bio

Article Title: Delivery of extracellular vesicles loaded with immune checkpoint inhibitors for immunotherapeutic management of glioma

doi: 10.1016/j.mtbio.2024.101244

Figure Lengend Snippet: Barrier permeation enhancement effect of EVs and efficient delivery of aPD-L1/EV into brain. ( A ) Scheme of the in vitro barrier permeation test with C2BBe1 trans-well system (created from Biorender.com ). ( B ) Amounts of permeated aPD-L1 with free aPD-L1 or aPD-L1/EV administration through the C2BBe1 barrier. ( C ) Comparison of drug delivery efficiency with RO or IN administration of FITC-conjugated IgG or IgG/EV. The upper column displays the fluorescence of IgG within brain sections, and the lower column shows the cumulative fluorescence intensity of brain sections. ( D ) Distribution of aPD-L1 in GL261 tumor-bearing mice. Green fluorescence indicates aPD-L1, and nuclei were stained with DAPI. Statistics in ( B, C ) were conducted by one-way ANOVA with Bonferroni post hoc test. Asterisks represent a significant difference between indicated groups, with significance defined as p < 0.05. Data were presented as mean ± SD with n = 3.

Article Snippet: The GL261-luc murine glioblastoma cell line was purchased from Creative Biolabs (Shirley, NY, USA).

Techniques: In Vitro, Comparison, Fluorescence, Staining

Therapeutic effect of ICI/EVs in managing orthotopic GL261 tumors. ( A ) Schematic of experimental procedures for GL261 tumor management (created from Biorender.com ). ( B, C ) Tumor volumes were evaluated with IVIS, and representative images are shown in ( B ). Changes in tumor volume were calculated based on the total flux observed on day 0 ( C ). ( D ) The survival of orthotopic GL261 tumor-bearing mice post-treatment was analyzed. The aPD-L1/EV + aCTLA-4/EV group demonstrated an extended survival time compared to other treatment groups. ( E ) Ki67 staining of GL261 tumors. Scale bar: 50 μm. Statistics for ( C ) were obtained from GLM with Bonferroni post hoc test, and for ( D ) from the Kaplan-Meier survival analysis with log rank test. The asterisk in ( C ) indicates a significant difference from the PBS and aPD-L1 treatments. In ( D ), the asterisk and hash signs represent significant difference from all treatment groups and from the PBS group, respectively. Significance was defined as p < 0.05. Data are presented as mean ± SEM with n = 4 in ( C ) and in ( D ) with n = 8∼18.

Journal: Materials Today Bio

Article Title: Delivery of extracellular vesicles loaded with immune checkpoint inhibitors for immunotherapeutic management of glioma

doi: 10.1016/j.mtbio.2024.101244

Figure Lengend Snippet: Therapeutic effect of ICI/EVs in managing orthotopic GL261 tumors. ( A ) Schematic of experimental procedures for GL261 tumor management (created from Biorender.com ). ( B, C ) Tumor volumes were evaluated with IVIS, and representative images are shown in ( B ). Changes in tumor volume were calculated based on the total flux observed on day 0 ( C ). ( D ) The survival of orthotopic GL261 tumor-bearing mice post-treatment was analyzed. The aPD-L1/EV + aCTLA-4/EV group demonstrated an extended survival time compared to other treatment groups. ( E ) Ki67 staining of GL261 tumors. Scale bar: 50 μm. Statistics for ( C ) were obtained from GLM with Bonferroni post hoc test, and for ( D ) from the Kaplan-Meier survival analysis with log rank test. The asterisk in ( C ) indicates a significant difference from the PBS and aPD-L1 treatments. In ( D ), the asterisk and hash signs represent significant difference from all treatment groups and from the PBS group, respectively. Significance was defined as p < 0.05. Data are presented as mean ± SEM with n = 4 in ( C ) and in ( D ) with n = 8∼18.

Article Snippet: The GL261-luc murine glioblastoma cell line was purchased from Creative Biolabs (Shirley, NY, USA).

Techniques: Staining

Immune cells in GL261 tumors post treatment. ( A ) IHC images of cytotoxic T cells within the tumor tissue. Green fluorescence indicates CD8 expression on T cells, while nuclei are counterstained with DAPI. Scale bar: 50 μm. ( B ) IHC images of M1 macrophages within tumor tissue. Green fluorescence indicates F4/80-stained macrophages, and red fluorescence indicates iNOS expression. Nuclei are counterstained with DAPI. Scale bar: 20 μm. ( C-E ) Flow cytometry analysis results for total T cells ( C ), cytotoxic T cells ( D ), and M1 macrophages ( E ). Statistics for ( C, D, E ) were obtained from one-way ANOVA with Bonferroni post hoc test, with significance defined as p < 0.05. Data are expressed as mean ± SEM with n = 5.

Journal: Materials Today Bio

Article Title: Delivery of extracellular vesicles loaded with immune checkpoint inhibitors for immunotherapeutic management of glioma

doi: 10.1016/j.mtbio.2024.101244

Figure Lengend Snippet: Immune cells in GL261 tumors post treatment. ( A ) IHC images of cytotoxic T cells within the tumor tissue. Green fluorescence indicates CD8 expression on T cells, while nuclei are counterstained with DAPI. Scale bar: 50 μm. ( B ) IHC images of M1 macrophages within tumor tissue. Green fluorescence indicates F4/80-stained macrophages, and red fluorescence indicates iNOS expression. Nuclei are counterstained with DAPI. Scale bar: 20 μm. ( C-E ) Flow cytometry analysis results for total T cells ( C ), cytotoxic T cells ( D ), and M1 macrophages ( E ). Statistics for ( C, D, E ) were obtained from one-way ANOVA with Bonferroni post hoc test, with significance defined as p < 0.05. Data are expressed as mean ± SEM with n = 5.

Article Snippet: The GL261-luc murine glioblastoma cell line was purchased from Creative Biolabs (Shirley, NY, USA).

Techniques: Fluorescence, Expressing, Staining, Flow Cytometry